These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3836365)

  • 1. [Clinical, pathologic and HLA antigen markers of heterogeneity associated with myasthenia gravis].
    Apostolski S; Krstić S; Gospavić J; Miletić V; Lazić D; Stolić I
    Neurologija; 1985; 34(1-4):47-58. PubMed ID: 3836365
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-immunological features of generalized myasthenia in patients with hyperplasia and atrophy of the thymus gland].
    Vetshev PS; Zaĭrat'iants OV; Ippolitov IKh; Belokrinitskiĭ DV; Shkrob LO; Khodzhaev ZSh; Kurochkin AV
    Klin Med (Mosk); 1991 Dec; 69(12):78-83. PubMed ID: 1787688
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.
    Compston DA; Vincent A; Newsom-Davis J; Batchelor JR
    Brain; 1980 Sep; 103(3):579-601. PubMed ID: 6968236
    [No Abstract]   [Full Text] [Related]  

  • 4. [Main histocompatibility HLA system antigens in myasthenia gravis].
    Kastelan A; Jusić A
    Neurologija; 1979; 27(1-4):155-62. PubMed ID: 262004
    [No Abstract]   [Full Text] [Related]  

  • 5. Myasthenia gravis and sarcoidosis: report of 2 cases.
    De Bleecker J; van Aken L; van Landegem W; van den Abeele G; Cuvelier C
    Eur Neurol; 1996; 36(5):326-7. PubMed ID: 8864719
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of thymic pathology with HLA in myasthenia gravis.
    Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
    Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic importance of thymic germinating centers in cases of myasthenia gravis pseudoparalytica].
    Schönfelder M; Baumann I
    Psychiatr Neurol Med Psychol (Leipz); 1974 Sep; 26(9):556-64. PubMed ID: 4449919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some clinical problems in myasthenia (Case records from the Warsaw Neurologic Clinic].
    Hausmanowa-Petrusewicz I
    Z Arztl Fortbild (Jena); 1971 Apr; 65(8):401-4. PubMed ID: 5006535
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic factors in myasthenia gravis: a family study.
    Kerzin-Storrar L; Metcalfe RA; Dyer PA; Kowalska G; Ferguson I; Harris R
    Neurology; 1988 Jan; 38(1):38-42. PubMed ID: 3336461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mast cell density and microvessel density in the thymus of patients with myasthenia gravis.
    Raica M; Cîmpean AM; Encică S; Scridon T; Bârsan M
    Rom J Morphol Embryol; 2007; 48(1):11-6. PubMed ID: 17502945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical therapy of myasthenia gravis and thymoma].
    Bertram P; Treutner KH; Winkeltau G; Schumpelick V
    Chirurg; 1993 Oct; 64(10):796-801. PubMed ID: 8269744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution of B-lymphocyte subgroup CD20 and its clinical significance in patients with myasthenia gravis].
    Zhang Q; Hu Y; Zhang L; Li Y; Yin H; Li J
    Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):239-41. PubMed ID: 11825378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital myasthenia gravis. A case report with thymectomy and electron microscopic study of resected thymus.
    Clarke RR; Van de Velde RL
    Am J Dis Child; 1971 Oct; 122(4):356-61. PubMed ID: 4107215
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors affecting response to thymectomy for myasthenia gravis.
    Rubin JW; Ellison RG; Moore HV; Pai GP
    J Thorac Cardiovasc Surg; 1981 Nov; 82(5):720-8. PubMed ID: 7300404
    [No Abstract]   [Full Text] [Related]  

  • 15. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
    Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis].
    Sund KK; Skeie GO; Gilhus NE; Aarli JA; Varhaug JE
    Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4212-4. PubMed ID: 9441462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.
    Osserman KE; Genkins G
    Mt Sinai J Med; 1971; 38(6):497-537. PubMed ID: 4941403
    [No Abstract]   [Full Text] [Related]  

  • 19. Myasthenia gravis.
    Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the thymus in patients with myasthenia and their importance for the choice of surgical approach].
    Kuzin MI; Kabanov NIa
    Grudn Khir; 1966; 8(3):92-5. PubMed ID: 5981532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.